If you’ve ever felt that sudden, overwhelming wave of heat—the telltale sign of a hot flash—you know how disruptive and ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Bayer (BAYZF) (BAYRY) says elinzanetant, its experimental therapy for hot flashes, reached the main goals in a late-stage ...

I did not finish that yoga class. Instead, I rolled up my mat and fled the studio for the air-conditioned bathroom where I ...

Hepatic function should be evaluated prior to initiating treatment with Veozah. The prescribing information for Veozah (fezolinetant) has been updated to include a boxed warning regarding the risk of ...

The study published in Nature Cells highlights the molecular mechanisms and treatment strategies. Men with Klinefelter's syndrome have an extra X chromosome, meaning their genetic makeup is “47 ...

Treatment with vibegron reduced the average ... “The FDA’s expanded approval of Gemtesa is an important milestone for the men with unresolved symptoms of OAB while being treated for BPH ...

SSRIs and selective norepinephrine reuptake inhibitors (SNRIs) have been extensively studied for the management of hot flashes with varying results. [1] In this well-done trial, escitalopram at ...